Fulminant Hepatic Failure clinical trials at UCSF
1 research study open to eligible people
Fulminant hepatic failure happens when the liver fails very quickly. UCSF is conducting trials to find better treatments for children with this issue. These trials include testing medicines that affect the immune system.
TReatment for ImmUne Mediated PathopHysiology
open to eligible people ages 1-18
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.
San Francisco, California and other locations
Last updated: